OTC Markets OTCPK - Delayed Quote USD

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

1.2400
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Loading Chart for GNMLF
  • Previous Close 0.0000
  • Open 1.2400
  • Bid 1.0400 x 40000
  • Ask 1.1600 x 40000
  • Day's Range 1.2400 - 1.2400
  • 52 Week Range 0.9200 - 1.4300
  • Volume 300
  • Avg. Volume 29
  • Market Cap (intraday) 1.208B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 11.27
  • EPS (TTM) 0.1100
  • Earnings Date Jul 22, 2025 - Jul 28, 2025
  • Forward Dividend & Yield 0.04 (3.21%)
  • Ex-Dividend Date Mar 13, 2025
  • 1y Target Est --

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

www.genommalab.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GNMLF

View More

Performance Overview: GNMLF

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/BMV IPC (^MXX) .

YTD Return

GNMLF
13.51%
S&P/BMV IPC (^MXX)
14.21%

1-Year Return

GNMLF
194.42%
S&P/BMV IPC (^MXX)
2.24%

3-Year Return

GNMLF
2,098.11%
S&P/BMV IPC (^MXX)
15.28%

5-Year Return

GNMLF
42,999.47%
S&P/BMV IPC (^MXX)
50.31%

Compare To: GNMLF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GNMLF

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    1.07B

  • Enterprise Value

    1.31B

  • Trailing P/E

    11.08

  • Forward P/E

    10.81

  • PEG Ratio (5yr expected)

    0.53

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    2.13

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    5.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.03%

  • Return on Assets (ttm)

    11.25%

  • Return on Equity (ttm)

    21.11%

  • Revenue (ttm)

    18.82B

  • Net Income Avi to Common (ttm)

    2.2B

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.16B

  • Total Debt/Equity (mrq)

    62.63%

  • Levered Free Cash Flow (ttm)

    1.28B

Research Analysis: GNMLF

View More

Company Insights: GNMLF

Research Reports: GNMLF

View More

People Also Watch